期刊文献+

371株深部感染真菌的菌群分布及药物敏感性分析 被引量:4

Analysis of the distribution and drug susceptibility of 371 fungi strains resulting in deep infections.
下载PDF
导出
摘要 目的 了解中山大学附属第一医院检出深部感染真菌的菌群分布及药物敏感性状况 ,为临床治疗提供参考依据。 方法 所分离出的真菌用API 2 0CAUX鉴定 ,用ATBFUNGUS进行药敏实验。 结果  3 71株真菌中白色念珠菌 2 2 8株、热带念珠菌 73株、光滑念珠菌 3 8株、近平滑念珠菌 12株、无名酵母菌 6株、新型隐球菌 3株、平常念珠菌 3株、季也蒙念珠菌 2株。 3 71株真菌对 5 -氟胞嘧啶、两性霉素B、制菌霉素、咪康唑、益康唑、酮康唑总的敏感率分别为 92 %、97%、96%、5 7%、63 %、69%。 结论 深部真菌感染主要由白色念珠菌、热带念珠菌、光滑念珠菌引起。对两性霉素B、制菌霉素、5 -氟胞嘧啶的敏感性最高 ,保持了较高的抗菌活性 ,这三种抗菌药仍然是治疗深部真菌感染的有效药物。 Objective To investigate the distribution and drug resistance situation of the fungi which caused deep part infection. Methods The isolated fungi were indentified with API 20C AUX and drug susceptibility tests was conducted by using ATB FUNGUS. Results 228 strains of Candida albicans, 73 strains of Candida tropicalis, 38 strains of Candida glabrata, 12 strains of Candida papasilosis, 6 strains of Candida famata, 3 strains of Cryptococcus neofermans, 3 strains of Candida inconspicua, 2 strains of Candida guilliermondii were isolated. The total sensitivity of 371 strains of fungi to 5-fluorocytosine, amphotericin B, mycomycin, miconazole, econazole, ketoconazole were 92%,97%,96%,57%,63%,69%,respectively. Conclusion The dominant pathogenic fungi which caused deep part infection were Candida albicans, Candida tropicalis and Candida glabrata. Amphotericin B, mycomycin and 5-fluorocytosine were most sensitive to the pathogenic fungi and remain to be the most effective drug to cure deep part infection.
出处 《中国热带医学》 CAS 2004年第5期767-768,772,共3页 China Tropical Medicine
  • 相关文献

参考文献5

二级参考文献22

  • 1陈世平,索继江,孙鹤龄.机会真菌及其感染机制研究的进展[J].军医进修学院学报,1993,14(4):288-291. 被引量:1
  • 2李冬梅,王端礼,李若瑜,万喆,王晓红,周祖德,李小兵,朱立煌.致病性念珠菌菌种的变迁[J].中华皮肤科杂志,1995,28(6):375-378. 被引量:15
  • 3杜斌,陈德昌,刘大为,徐英春,谢秀丽,陈民钧.综合性加强医疗病房的获得性细菌感染[J].中华医学杂志,1996,76(4):262-266. 被引量:39
  • 4刘胜文.我国医院感染暴发事例剖析与对策[A]..第五届全国医院感染管理学术会议论文集[C].宁波,1998.16-18.
  • 5陈世平 索继江.医院真菌感染及其研究现状[A]..全国医院感染管理学术会议论文集[C].成都,2000.6-9.
  • 6[1]Andriole VT. Current and future therapy of invasive fungal infections[J]. In Current clinical Topics in Infectious Diseases[J], Vol. 18:19 ~ 36, BlackwellScience, Malden, MA. 1998.
  • 7[2]Dismukes WE. Introduction to antifungal drugs[J]. Clin Infect Dis, 2000,30:653~657.
  • 8[3]Wong- Beringer A,Jacobs RA, Guglielmo BJ. Lipid formulations of anphotericin B:clinical efficacy and toxicities[J]. Clin Infect Dis, 1998,27:603~618.
  • 9[4]Sharkey DK,Graybill JR,Johnson RD,et al. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS[J]. Clin Infect Dis, 1996,22:315~321.
  • 10[5]Cruz JM,Peacock JE Jr, Loomer L,et al. Rapid intravenous infusion of amphotericin B[J]: a pilot study. Am J Med, 1992:123~130.

共引文献211

同被引文献20

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部